Duchenne Muscular Dystrophy results because of the mutations in the dystrophin gene. This gene is crucial for muscle function. The condition can result in cardiovascular disability, progressive breathing, and serious muscle weakness. The disease manifests by resulting in extreme muscle fatigue followed by the loss of ability to walk by the age of 7. Deflazacort cannot be considered to be a cure for muscular dystrophy. However, it does strengthen the muscles and also slows down the progression of disability. The NHS prescription price for 6mg of this drug is £9.00. The wholesale cost may be a little lesser than this. Apart from being beneficial to muscles, this drug can also help with conditions such as Asthma, Crohn’s Disease, Lymphatic Leukemia, multiple myeloma, Pemphigus, Sarcoidosis, Ulcerative colitis, juvenile chronic arthritis and many more. The conditions have now changed as far as the wholesale price of this drug is concerned. As the drug has been approved in several nations, the Deflazacort manufacturers are now offering it at lower rates. For instance, in Canada, the drug can be purchased for $1 per tablet. The Deflazacort suppliers are offering this drug under the trade name after the rights were purchased by PTC Therapeutics Inc. from Marathon Pharmaceuticals. In the United Kingdom, Deflazacort suppliers use the trade name Calcort. In Brazil, the distributors use the trade name Cortax or Defcort. If you are a distributor, then you can make good use of the opportunity available and secure a great deal for Deflazacort from the leading manufacturers on Pipelinepharma. You can achieve the best cost/benefit ratio by bypassing lengthy sourcing, negotiation, and ordering process.